Rybrevant and Acetaminophen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rybrevant (amivantamab-vmjw) and Acetaminophen (acetaminophen). Common drug interactions include infusion related reaction among females and generalised oedema among males.
The phase IV clinical study analyzes what interactions people have when they take Rybrevant and Acetaminophen. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Rybrevant?
Rybrevant has active ingredients of amivantamab-vmjw. eHealthMe is studying from 560 Rybrevant users. Check the latest studies of Rybrevant.
What is Acetaminophen?
Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.
18 people who take Rybrevant and Acetaminophen together, and have interactions are studied.

What are the common drug interactions of Rybrevant and Acetaminophen, by gender? *:
female:
- Infusion related reaction
- Nausea (feeling of having an urge to vomit)
- Dyspnoea (difficult or laboured respiration)
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Dry skin
- Oxygen saturation decreased
- Peripheral swelling
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
male:
- Generalised oedema (swelling all over the body)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Pleural effusion (water on the lungs)
- Pulmonary infarction (death of a small area of lung)
- Renal disorder (kidney disease)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Blood pressure increased
- Infusion related reaction
- Rash
- Respiratory rate increased (excess breathing rate/min)
What are the common drug interactions of Rybrevant and Acetaminophen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Infusion related reaction
- Nausea (feeling of having an urge to vomit)
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Dry skin
- Dyspnoea (difficult or laboured respiration)
- Oxygen saturation decreased
- Peripheral swelling
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Erythema (redness of the skin)
60+:
- Generalised oedema (swelling all over the body)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Metabolic alkalosis (too much bicarbonate in the blood)
- Pleural effusion (water on the lungs)
- Pulmonary infarction (death of a small area of lung)
- Renal disorder (kidney disease)
- Rash
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Infusion related reaction
- Fall
What are the existing conditions these people have? *
- Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 27.78%
- Lung Cancer - Non-Small Cell (lung cancer): 4 people, 22.22%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 16.67%
- Non-Small Cell Lung Cancer Stage Iv: 2 people, 11.11%
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 2 people, 11.11%
- Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 11.11%
- Lung Neoplasm (tumour of lung): 2 people, 11.11%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
- Abdominal Pain: 2 people, 11.11%
- Metastases To Peritoneum (cancer spreads to peritoneum): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Rybrevant and Acetaminophen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rybrevant (560 reports)
- Acetaminophen (183,077 reports)
Browse all drug interactions of Rybrevant and Acetaminophen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rybrevant:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Acetaminophen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rybrevant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acetaminophen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amivantamab-vmjw and acetaminophen (the active ingredients of Rybrevant and Acetaminophen, respectively), and Rybrevant and Acetaminophen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cosentyx and Peripheral Coldness for Men aged 50-59 - 9 seconds ago
- Flonase and Hallucinations for Women aged 60+ - 11 seconds ago
- Flonase and Hallucination for Women aged 60+ - 11 seconds ago
- Flonase and Sensory Hallucinations for Women aged 60+ - 12 seconds ago
- Genital Herpes and drugs of ingredients of fentanyl citrate - 14 seconds ago
- Drug interactions of Luvox and Pradaxa - 21 seconds ago
- Nucala and Dyspnoea for Women aged 50-59 - 28 seconds ago
- Nucala and Dyspnea for Women aged 50-59 - 28 seconds ago
- Senile Dementia and drugs of ingredients of lithium carbonate - 30 seconds ago
- Omeprazole and Pseudomembranous Colitis for Men aged 20-29 - 34 seconds ago